(PRMB) Primo Brands - Overview
Stock: Bottled Water, Dispensers, Filtration, Refill, Delivery
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.69% |
| Yield on Cost 5y | 2.59% |
| Yield CAGR 5y | 13.62% |
| Payout Consistency | 52.7% |
| Payout Ratio | 33.6% |
| Risk 5d forecast | |
|---|---|
| Volatility | 32.4% |
| Relative Tail Risk | -10.8% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.10 |
| Alpha | -49.29 |
| Character TTM | |
|---|---|
| Beta | 0.412 |
| Beta Downside | 0.612 |
| Drawdowns 3y | |
|---|---|
| Max DD | 59.12% |
| CAGR/Max DD | 0.18 |
Description: PRMB Primo Brands January 03, 2026
Primo Brands Corporation (NYSE: PRMB) is a North-American branded-beverage company that focuses on water solutions, ranging from point-of-use dispensers and refillable bottle delivery to self-service refill stations and home filtration appliances.
The firm markets a broad portfolio of packaged water brands-including Poland Spring, Pure Life, Arrowhead, Deer Park, Ice Mountain, Ozarka, and Zephyrhills-alongside its own Primo Water and Sparkletts purified lines and newer flavored/enhanced offerings such as AC+ION and Splash Refresher. Distribution spans direct-to-consumer, retail, residential, e-commerce, on-premise, and commercial channels.
According to Primo’s FY 2023 filing, total revenue was approximately **$1.42 billion**, with an adjusted EBITDA margin of **~10 %** and free cash flow of **$120 million**. The balance sheet shows **$1.1 billion** of total debt, net of cash, giving a net-debt-to-EBITDA ratio near **1.1×**, which is modest for the sector.
Key economic drivers for Primo include the **U.S. bottled-water market’s 5-year CAGR of ~4 %**, accelerated by consumer preferences for sustainable, refillable packaging and by rising health-consciousness. Inflationary pressure on packaging inputs (PET resin) and potential regulatory caps on single-use plastics represent material risks that could affect margins.
For a deeper quantitative view, you might explore ValueRay’s analyst dashboard to see how Primo’s valuation compares to peers.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: -84.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -2.80 > 1.0 |
| NWC/Revenue: 0.50% < 20% (prev 14.14%; Δ -13.63% < -1%) |
| CFO/TA 0.06 > 3% & CFO 682.4m > Net Income -84.6m |
| Net Debt (5.28b) to EBITDA (875.2m): 6.03 < 3 |
| Current Ratio: 1.02 > 1.5 & < 3 |
| Outstanding Shares: last quarter (374.1m) vs 12m ago 130.8% < -2% |
| Gross Margin: 31.07% > 18% (prev 0.35%; Δ 3072 % > 0.5%) |
| Asset Turnover: 89.63% > 50% (prev 113.6%; Δ -23.96% > 0%) |
| Interest Coverage Ratio: 0.99 > 6 (EBITDA TTM 875.2m / Interest Expense TTM 334.9m) |
Altman Z'' -0.47
| A: 0.00 (Total Current Assets 1.47b - Total Current Liabilities 1.43b) / Total Assets 10.96b |
| B: -0.17 (Retained Earnings -1.84b / Total Assets 10.96b) |
| C: 0.05 (EBIT TTM 332.2m / Avg Total Assets 7.26b) |
| D: -0.24 (Book Value of Equity -1.85b / Total Liabilities 7.80b) |
| Altman-Z'' Score: -0.47 = B |
Beneish M -1.74
| DSRI: 1.84 (Receivables 550.0m/185.8m, Revenue 6.51b/4.05b) |
| GMI: 1.13 (GM 31.07% / 35.09%) |
| AQI: 1.18 (AQ_t 0.62 / AQ_t-1 0.53) |
| SGI: 1.61 (Revenue 6.51b / 4.05b) |
| TATA: -0.07 (NI -84.6m - CFO 682.4m) / TA 10.96b) |
| Beneish M-Score: -1.74 (Cap -4..+1) = CCC |
What is the price of PRMB shares?
Over the past week, the price has changed by +3.64%, over one month by +21.85%, over three months by +11.65% and over the past year by -40.47%.
Is PRMB a buy, sell or hold?
- StrongBuy: 5
- Buy: 4
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the PRMB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 28.4 | 44.6% |
| Analysts Target Price | 28.4 | 44.6% |
| ValueRay Target Price | 19.6 | -0.3% |
PRMB Fundamental Data Overview February 03, 2026
P/S = 1.0778
P/B = 2.1938
Revenue TTM = 6.51b USD
EBIT TTM = 332.2m USD
EBITDA TTM = 875.2m USD
Long Term Debt = 5.02b USD (from longTermDebt, last quarter)
Short Term Debt = 164.1m USD (from shortTermDebt, last quarter)
Debt = 5.70b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.28b USD (from netDebt column, last quarter)
Enterprise Value = 11.32b USD (6.04b + Debt 5.70b - CCE 422.7m)
Interest Coverage Ratio = 0.99 (Ebit TTM 332.2m / Interest Expense TTM 334.9m)
EV/FCF = 27.70x (Enterprise Value 11.32b / FCF TTM 408.5m)
FCF Yield = 3.61% (FCF TTM 408.5m / Enterprise Value 11.32b)
FCF Margin = 6.28% (FCF TTM 408.5m / Revenue TTM 6.51b)
Net Margin = -1.30% (Net Income TTM -84.6m / Revenue TTM 6.51b)
Gross Margin = 31.07% ((Revenue TTM 6.51b - Cost of Revenue TTM 4.49b) / Revenue TTM)
Gross Margin QoQ = 29.91% (prev 31.26%)
Tobins Q-Ratio = 1.03 (Enterprise Value 11.32b / Total Assets 10.96b)
Interest Expense / Debt = 1.46% (Interest Expense 83.1m / Debt 5.70b)
Taxrate = 39.46% (26.4m / 66.9m)
NOPAT = 201.1m (EBIT 332.2m * (1 - 39.46%))
Current Ratio = 1.02 (Total Current Assets 1.47b / Total Current Liabilities 1.43b)
Debt / Equity = 1.80 (Debt 5.70b / totalStockholderEquity, last quarter 3.16b)
Debt / EBITDA = 6.03 (Net Debt 5.28b / EBITDA 875.2m)
Debt / FCF = 12.92 (Net Debt 5.28b / FCF TTM 408.5m)
Total Stockholder Equity = 3.30b (last 4 quarters mean from totalStockholderEquity)
RoA = -1.17% (Net Income -84.6m / Total Assets 10.96b)
RoE = -2.57% (Net Income TTM -84.6m / Total Stockholder Equity 3.30b)
RoCE = 4.00% (EBIT 332.2m / Capital Employed (Equity 3.30b + L.T.Debt 5.02b))
RoIC = 2.41% (NOPAT 201.1m / Invested Capital 8.36b)
WACC = 4.25% (E(6.04b)/V(11.74b) * Re(7.43%) + D(5.70b)/V(11.74b) * Rd(1.46%) * (1-Tc(0.39)))
Discount Rate = 7.43% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 52.65%
[DCF Debug] Terminal Value 88.43% ; FCFF base≈338.1m ; Y1≈417.1m ; Y5≈710.3m
Fair Price DCF = 41.61 (EV 20.68b - Net Debt 5.28b = Equity 15.41b / Shares 370.3m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 60.70 | EPS CAGR: 42.03% | SUE: 1.02 | # QB: 1
Revenue Correlation: 79.00 | Revenue CAGR: 38.69% | SUE: N/A | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.32 | Chg30d=-0.043 | Revisions Net=-5 | Analysts=10
EPS next Year (2026-12-31): EPS=1.47 | Chg30d=-0.164 | Revisions Net=-8 | Growth EPS=+16.0% | Growth Revenue=+3.0%